Workflow
Zhiyang Innovation Technology (688191)
icon
Search documents
智洋创新(688191) - 第四届董事会第十八次会议决议公告
2026-02-25 11:15
证券代码:688191 证券简称:智洋创新 公告编号:2026-010 智洋创新科技股份有限公司 (一)审议通过《关于终止重大资产重组并变更为战略投资事项的议案》 第四届董事会第十八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 1、智洋创新科技股份有限公司(以下简称"公司")第四届董事会第十八 次会议,已于 2026 年 2 月 24 日以电话、邮件等方式向全体董事发出会议通知。 本次会议为紧急会议,全体董事一致同意豁免本次会议的通知时效。 2、会议于 2026 年 2 月 25 日上午 11 点在公司会议室以现场及通讯方式召开。 本次会议应出席董事 9 名,实际出席董事 9 名,刘国永、聂树刚、赵砚青、陈晓 娟、李奇凤、谭博学、漆彤以通讯方式参加,其余董事以现场方式参加。 3、本次会由董事长刘国永先生主持,公司高级管理人员列席本次董事会会 议。 4、本次董事会会议的召集召开符合有关法律、行政法规、部门规章、规范 性文件及《公司章程》的规定。 二、董事会会议审议情况 本次会议由董 ...
智洋创新(688191.SH):公司股票将于2月26日起复牌
Ge Long Hui· 2026-02-25 11:08
格隆汇2月25日丨智洋创新(688191.SH)公布,智洋创新科技股份有限公司因筹划以发行人民币普通股股 票、定向发行可转换公司债券(如有)、支付现金(如有)等方式购买深圳市灵明光子科技有限公司控股 权,同时拟募集配套资金的事项,公司股票自2026年2月4日(星期三)开市起停牌。经审慎研究,公司决 定终止筹划本次重大资产重组事项,公司股票自2026年2月26日(星期四)开市起复牌。 ...
智洋创新:终止筹划重大资产重组事项 股票复牌
Mei Ri Jing Ji Xin Wen· 2026-02-25 11:06
每经AI快讯,2月25日,智洋创新(688191.SH)公告称,公司原计划以发行股票、定向可转债及支付现金 等方式购买灵明光子控股权,并募集配套资金。但受市场环境变化影响,交易双方未能就核心条款达成 一致,公司决定终止筹划本次重大资产重组。本次交易尚处筹划阶段,未签署正式协议,未提交审议, 也未实施,因此双方无需承担违约责任。公司股票将于2月26日复牌,并承诺1个月内不再筹划重大资产 重组。 (文章来源:每日经济新闻) ...
智洋创新(688191.SH):与深圳市灵明光子科技有限公司签署战略投资意向协议
Ge Long Hui A P P· 2026-02-25 11:02
格隆汇2月25日丨智洋创新(688191.SH)公布,公司与灵明光子签署了《战略投资意向协议》,约定终止 公司以发行人民币普通股股票及/或可转换公司债券、现金(如有)等方式收购标的公司股权的相关交 易,但同时公司拟以现金向标的公司进行增资及购买标的公司部分股权(如有),投资金额初步暂定为 3.00亿元,参照最近一轮融资投后估值,标的公司本次投前估值水平初步暂定为27亿元~30亿元,投后 持股比例约9.09%~10.00%,资金来源为自有及自筹资金;本次投资完成后,预计公司将成为标的公司 持股9%以上的重要股东,预计有权提名一名标的公司的董事候选人并拥有标的公司的整体出售否决 权,标的公司预计成为公司参股公司。截至目前,公司不存在谋求标的公司控制权的计划。本次投资金 额虽未达到提交公司股东会审议的标准,但仍将开展尽职调查、审计等相关事项,根据上述事项的结果 进一步确定估值水平,本次投资将先行支付5000万投资意向金。本次交易的投资价格、最终确定的投资 金额和标的公司投前估值水平等具体交易方案条款由各方另行协商并签订正式协议确定。 ...
智洋创新:终止重大资产重组,股票2月26日起复牌
Xin Lang Cai Jing· 2026-02-25 11:02
智洋创新公告称,公司原筹划以发行股份等方式购买灵明光子控股权并募集配套资金,预计构成重大资 产重组和关联交易,不会导致控制权变更。因市场环境变化,交易双方未就核心条款达成一致,公司决 定终止筹划。本次交易尚处筹划阶段,终止无需承担违约责任,不会对公司造成不利影响。公司股票自 2026年2月26日开市起复牌,承诺1个月内不再筹划重大资产重组。此外,公司将对标的公司进行参股投 资。 ...
智洋创新:拟以3亿元现金投资灵明光子
Mei Ri Jing Ji Xin Wen· 2026-02-25 11:00
每经AI快讯,2月25日,智洋创新(688191.SH)公告称,公司与深圳市灵明光子科技有限公司签署了《战 略投资意向协议》,终止以发行股票及/或可转换公司债券、现金等方式收购灵明光子股权的交易,但 拟以现金向灵明光子进行增资及购买部分股权,投资金额初步暂定为3.00亿元,投前估值水平初步暂定 为27亿元~30亿元,投后持股比例约9.09%~10.00%。预计公司将成为灵明光子持股9%以上的重要股 东,有权提名一名董事候选人并拥有整体出售否决权。投资金额虽未达到提交股东会审议的标准,但仍 将开展尽职调查、审计等相关事项,根据结果进一步确定估值水平,本次投资将先行支付5,000万投资 意向金。 ...
智洋创新科技股份有限公司关于筹划重大资产重组事项进展并继续停牌的公告
Core Viewpoint - The company, Zhiyang Innovation Technology Co., Ltd., is planning a significant asset restructuring by acquiring control of Shenzhen Lingming Photon Technology Co., Ltd. through various means including issuing ordinary shares and convertible bonds, as well as cash payments [1][2]. Group 1 - The company has applied for a trading suspension of its stock starting from February 4, 2026, with an expected duration of no more than five trading days [1]. - As of the announcement date, the involved parties are actively advancing the transaction, but the company anticipates that it will not be able to resume trading on February 11, 2026, due to significant uncertainties surrounding the matter [2]. - The company will continue to disclose information in accordance with legal regulations during the trading suspension and will announce the resumption of trading once the matters are confirmed [2].
2月10日晚间重要公告一览
Xi Niu Cai Jing· 2026-02-10 10:19
Group 1 - Baichuan Co., Ltd. announced a recent price increase for some of its main products due to market supply and demand factors, but the sustainability of this price fluctuation remains uncertain, making it difficult to predict the impact on the company's performance [1] - Jincheng Co., Ltd. plans to increase its acquisition of CMH Company by an additional 42.50% stake, which will give it a total ownership of 97.5% and ultimate control over CMH [2] - Xinhang New Materials intends to raise no more than 1 billion yuan through a private placement of A-shares, with the funds allocated for projects including high-performance resin production and a composite materials innovation center [3] Group 2 - SMIC reported a sales revenue of $2.489 billion for Q4 2025, a 4.5% increase quarter-on-quarter, with an annual revenue of $9.327 billion, reflecting a 16.2% year-on-year growth [4] - China Railway Construction recently won 10 major projects, each valued over 1.5 billion yuan, totaling 45.142 billion yuan, which represents 4.23% of the company's audited revenue for 2024 [5] - Shenzhen Airport recorded a passenger throughput of 5.8795 million in January 2026, a year-on-year increase of 2.84% [6] Group 3 - China State Construction reported a new contract total of 399.5 billion yuan in January 2026, marking a 1.8% year-on-year increase [7] - Jindi Group's sales amount in January 2026 decreased by 45.78% year-on-year, with a signed area of 78,000 square meters [8] - Changyuan Power achieved a power generation of 3.971 billion kWh in January 2026, a year-on-year increase of 37.81% [9] Group 4 - Senyuan Electric is expected to win a project from the Southern Power Grid valued at 272 million yuan [10] - Chengyi Pharmaceutical's products are set to be selected for the national centralized procurement of expiring varieties [12] - Xinwufeng reported a 10.71% year-on-year decrease in pig sales volume in January 2026 [13] Group 5 - Shengnong Development's sales revenue in January 2026 increased by 40.48% year-on-year, with chicken sales volume rising by 42.79% [14] - Minglida announced the termination of its investment in a key component manufacturing project due to global economic uncertainties [15] - CITIC Securities reported that its subsidiary, Huaxia Fund, achieved a net profit of 2.396 billion yuan in 2025 [16] Group 6 - Pianzaihuang completed the first subject enrollment for its Phase II clinical trial of PZH2107 [17] - Xinzhou Bang reported a 16.56% year-on-year increase in net profit for 2025 [18] - Ankai Bus produced 761 vehicles in January 2026, a year-on-year increase of 35.65% [19] Group 7 - Weilan Bio plans to acquire a 50% stake in Aidimeng Weilan for 47 million yuan [20] - Ningbo Gaofa intends to establish a wholly-owned subsidiary with an investment of no more than 100 million yuan [21] - Shanghai Airport signed a leasing contract worth approximately 585 million yuan with the Shanghai Airport Group [22] Group 8 - Fosun Pharma's subsidiary received acceptance for a drug registration application [23] - Jindai Home's subsidiary invested in acquiring shares in a North American market company [24] - Huatong Co. reported a 1.45% year-on-year decrease in pig sales revenue in January 2026 [25] Group 9 - Yunnan Energy Investment's Nanchong Wind Power Project has been approved with a total installed capacity of 62,500 kW [28] - Youyan Silicon reported a 10.14% year-on-year decrease in net profit for 2025 [29] - Jinpu Titanium announced a temporary shutdown of its Nanjing Titanium White production due to reduced demand [30] Group 10 - Yipin Hong completed the sale of its stake in Arthrosi for a total of $9.5 billion in upfront payments [31] - Liande Co. stated that its gas turbine business currently has limited supply, with minimal impact on overall performance [32] - Tiens Wind Power signed new contracts worth 870 million yuan in the offshore engineering sector [33] Group 11 - Daqin Railway reported a freight volume of 31.28 million tons in January 2026, a year-on-year increase of 5% [34] - ST Mingcheng successfully dismissed all claims from Beijing Fusheng in a recent court ruling [35] - Zhiyang Innovation is planning to acquire control of Lingming Photon and will continue its stock suspension for up to five trading days [36][37] Group 12 - Fulai New Materials accelerated the commercialization of flexible sensors, preparing for mass production of its third-generation electronic skin products [38] - Minhe Co. reported a 36.89% year-on-year decrease in sales of broiler chicks in January 2026 [39] - Ruiang Gene received government subsidies totaling 2 million yuan [40] Group 13 - Huiyu Pharmaceutical's shareholder was forced to reduce holdings by 0.307% due to a court order [41] - Fuyuan Pharmaceutical's subsidiary obtained a drug registration certificate for a new oral solution [42] - Xuantai Pharmaceutical's product is set to be selected for national procurement [43] Group 14 - Chunqiu Electronics completed the cancellation of 9.1369 million repurchased shares [44] - Jinguang Electric won a bid worth approximately 28.8691 million yuan [45] - Hongda Co. plans to invest approximately 71.43 million yuan in a 110kV power transmission project [46] Group 15 - Nanchao Foods reported a 1.99% year-on-year decrease in revenue for January 2026 [47] - Shisheng Intelligent plans to repurchase shares worth between 17.5 million and 35 million yuan [48]
智洋创新(688191) - 关于筹划重大资产重组事项进展并继续停牌的公告
2026-02-10 08:15
关于筹划重大资产重组事项进展并继续停牌的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 证券代码:688191 证券简称:智洋创新 公告编号:2026-009 智洋创新科技股份有限公司 智洋创新科技股份有限公司董事会 2026 年 2 月 11 日 智洋创新科技股份有限公司(以下简称"公司")正在筹划以发行人民币普 通股股票、定向发行可转换公司债券(如有)、支付现金(如有)等方式购买深 圳市灵明光子科技有限公司控制权,同时拟募集配套资金(以下简称"本次交易")。 根据上海证券交易所的相关规定,经公司申请,公司股票(证券简称:智洋创新, 证券代码:688191)自 2026 年 2 月 4 日(星期三)开市起停牌,预计停牌时间 不超过 5 个交易日。具体内容详见公司于 2026 年 2 月 4 日刊登在上海证券交易 所网站(www.sse.com.cn)的《关于筹划重大资产重组的停牌公告》(公告编 号:2026-008)。 截至本公告披露日,相关各方正在积极推进本次交易的各项工作,公司预计 无法在 2026 年 2 ...
智洋创新(688191.SH):继续停牌
Ge Long Hui A P P· 2026-02-10 08:10
Core Viewpoint - The company Zhiyang Innovation (688191.SH) is unable to resume trading on February 11, 2026, due to significant uncertainties surrounding ongoing transactions, leading to an extension of its stock suspension for up to five trading days [1] Group 1 - The company is actively advancing various aspects of the ongoing transaction [1] - The stock suspension is in accordance with the Shanghai Stock Exchange's regulations to ensure fair information disclosure and protect investor interests [1] - The expected duration of the stock suspension is no more than five trading days [1]